One of the major targets of AKT is the mammalian target of rapamycin (mTOR) which is also a key regulator of cell growth, proliferation, differentiation, survival [17], tumor cell motility, invasion and cancer metastasis [18]. This evidence concerns the gene AKT1 and cancer.